Resource Library

Search All Resources

  • Clear All
The Rise of Benzodiazepines – Dangers and Answers (Part 2) | January 7, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #benzodiazepines  #tapering  

Dr. Christopher Blazes, MD, OHSU Addiction Psychiatry Fellowship Director, reviews methods for tapering patients off of benzodiazepines and provides answers to commonly asked questions.      

Date added: 01/7/21

The Rise of Benzodiazepines – Dangers and Answers (Part 1) | December 3, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #benzodiazepines  

Dr. Christopher Blazes, MD, breaks down the history of benzodiazepines, their use in the healthcare setting, as well as their dangers and answers to commonly asked questions.  

Date added: 12/3/20

SUD Care at Maamwesying, North Shore Community Health Services | October 1, 2020

Cheryl Hankard, Naandwe Noojimowin Program Manager, provides an overview of the program and services offered at Maamwesying, North Shore Community Health Services, Inc. and the Naandwe Noojimowin Program. The Naandwe Noojimowin Program serves the First Nations people, focusing on storytelling ...

Date added: 10/1/20

Challenges in Addressing the Evolving Opioid Crisis During COVID-19 | September 3, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #covid and SUD  #covid-19  

Dr. Marwan Haddad and Daniel Bryant, LPC, from the Weitzman Institute, shares information on how they have met their SUD patient needs during the COVID-19 pandemic.  

Date added: 09/3/20

Substance Use Disorders: Brains, Behavior & Diagnosis | August 6, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #benzodiazepine  #kratom  

Dr. Jonathan Robbins, an Assistant Professor of Medicine at Oregon Health & Science University, shares information to help interpret a “negative” benzodiazepine urine drug screen, discusses how to the determine next steps for further confirmatory testing and how to recognize ...

Date added: 08/6/20

Methamphetamine Use Disorder | July 16, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #harm reduction  #Methamphetamine Use Disorder  #methamphetamines  

In this presentation, Dr. Jessica Gregg and Dr. Ximena Levander from Oregon Health & Science University discuss the history, chemical structure and epidemiology of methamphetamine use disorder. They also discuss treatment for methamphetamine use disorder, the current status of pharmacologic ...

Date added: 07/16/20

Managing Pain in Patients with Substance Use Disorder | June 4, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #pain and addiction  #pain management  

Dr. Jonathan Robbins, Internal Medicine Physician at OHSU, shows how the neurobiology of pain mirrors the neurobiology of addiction and identifies ways to improve pain management in patients with substance use disorders.    

Date added: 06/4/20

“Don’t You Mean Clonazepam?” A 40-Year-Old Woman with Opioid Use Disorder Requesting Detoxification from Clonazolam (Novel/Designer Benzodiazepine) | May 21, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #benzodiazepine  #clonazolam  #opioid use disorder  

Dr. Ximena Levander, an Addiction Medicine & General Internal Medicine Fellow at Oregon Health & Science University, shares information to help interpret a "negative" benzodiazepine urine drug screen and determine next steps for further confirmatory testing and to recognize the ...

Date added: 05/21/20

SUD Peers in COVID-19: Challenges, Resiliency & Emerging Strategies | May 7, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #covid and SUD  #resilience  

Debra Buffaloboy, Peer Consultant for the Northwest Portland Area Indian Health Board, discusses the challenges of peer recovery for those with substance use disorder in the COVID-19 pandemic. She shares strategies for resiliency and providing services.

Date added: 05/7/20

Buprenorphine Prescribing in a Pandemic | April 16, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #buprenorphine  #medication access  

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews best practices for buprenorphine prescribing during COVID-19 and the changing regulations around prescribing. She also shares a sample model for increasing access to buprenorphine.

Date added: 04/16/20